ScholarIQanswers from OpenAlex & ORCID
John Zalcberg
ResearcherPublications, citations & collaboration network
John Zalcberg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John Zalcberg have?
ScholarIQindexed works
John Zalcberg has 687 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John Zalcberg have?
ScholarIQcitation count
John Zalcberg has 32,071 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John Zalcberg?
ScholarIQh-index
John Zalcberg has an h-index of 70 in OpenAlex.
What is the i10-index of John Zalcberg?
ScholarIQi10-index
John Zalcberg has an i10-index of 291 in OpenAlex.
What is the ORCID of John Zalcberg?
ScholarIQorcid
The ORCID for John Zalcberg is on the source record.
What is the OpenAlex record for John Zalcberg?
ScholarIQopenalex
The OpenAlex for John Zalcberg is on the source record.
What are the most-cited papers on John Zalcberg?
ScholarIQmost cited works
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs, Jiří Tomášek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira dos Santos, Giuseppe Aprile, David Ferry, Bohuslav Melichar, Mustapha Tehfé, Э. Э. Топузов, John Zalcberg, Ian Chau, William Campbell, Choondal Devan Sivanandan, Joanna Pikiel, Minori Koshiji, Yanzhi Hsu, Astra M. Liepa, Ling Gao, Jonathan D. Schwartz, Josep Tabernero
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Dongsheng Tu, Salvatore Siena, Simona Lamba, Sabrina Arena, Milo Frattini, Hubert Piessevaux, Eric Van Cutsem, Chris J. O’Callaghan, Shirin Khambata‐Ford, John Zalcberg, John Simes, Christos S. Karapetis, Alberto Bardelli, Sabine Tejpar
Delivering affordable cancer care in high-income countries
Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro
Randomized Trial of Coordinated Psychosocial Interventions Based on Patient Self-Assessments Versus Standard Care to Improve the Psychosocial Functioning of Patients With Cancer
Sue‐Anne McLachlan, Ann Allenby, Jane Matthews, Andrew Wirth, David W. Kissane, Michelle Bishop, J. Beresford, John Zalcberg
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
Trevor Leong, B. Mark Smithers, Karin Haustermans, Michael Michael, Val Gebski, Danielle Miller, John Zalcberg, Alex Boussioutas, Michael Findlay, Rachel O’Connell, Jaclyn Verghis, David J. Willis, Tomas Kron, Melissa Crain, William K. Murray, Florian Lordick, Carol J. Swallow, Gail Darling, John Simes, Rebecca Wong